EP2575784
ORAL DOSAGE FORMS OF BENDAMUSTINE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
1.6.2011EP published:
8.8.2018EP application number:
11727396.1
EPO information:
European Patent Register
Max expiry date:
31.5.2031
Title:
ORAL DOSAGE FORMS OF BENDAMUSTINE
Timeline
Today
1.6.2011EP application
8.8.2018EP Publication
Owner
Name:
Astellas Deutschland GmbHAddress:
Georg-Brauchle-Ring 64-66, 80992, München, DE
Inventor
Name:
COLLEDGE, JeffreyAddress:
AH Leiden, NL
Name:
OLTHOFF, MargarethaAddress:
AH Leiden, NL
Priority
Number:
11075047Date:
14.3.2011Country:
EP
Number:
10075231Date:
2.6.2010Country:
EP
Classification
Categories:
A61K 9/48, A61K 9/14, A61K 31/4184, A61K 47/10